AIMOVIG vs BREO ELLIPTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. AIMOVIG and BREO ELLIPTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	BREO ELLIPTA
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE
Manufacturer	Amgen Inc	Glaxo Grp Ltd
Dosage forms	Injectable, Solution	Powder
Drug class	—	—
Boxed warning	None	None

aimovig breo ellipta

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

ERENUMAB-AOOE

FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE

Manufacturer

Amgen Inc

Glaxo Grp Ltd

Dosage forms

Injectable, Solution

Powder

Drug class

—

Boxed warning

None

Frequently asked questions

What is the difference between Aimovig and Breo Ellipta?

Aimovig contains Erenumab-Aooe, while Breo Ellipta contains Fluticasone Furoate and Vilanterol Trifenatate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.